Bicheng Chen Selected Research

Tacrolimus (Prograf)

1/2020	Exploring the Mechanism of Skeletal Muscle in a Tacrolimus-Induced Posttransplantation Diabetes Mellitus Model on Gene Expression Profiles.
10/2019	Altered expression of glucose metabolism associated genes in a tacrolimus‑induced post‑transplantation diabetes mellitus in rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bicheng Chen Research Topics

Disease

27	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 01/2014
23	Neoplasms (Cancer) 01/2022 - 01/2014
17	Liver Cirrhosis (Hepatic Cirrhosis) 12/2020 - 02/2012
16	Pancreatitis 10/2022 - 02/2008
13	Inflammation (Inflammations) 05/2024 - 12/2013
11	Fibrosis (Cirrhosis) 04/2022 - 02/2012
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2016
6	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2014
5	Lung Injury 10/2022 - 12/2013
5	Carcinogenesis 01/2022 - 01/2016
5	Ureteral Obstruction 07/2017 - 06/2014
4	Acute Lung Injury 03/2020 - 12/2013
4	Diabetes Mellitus 01/2020 - 01/2016
3	Hypoxia (Hypoxemia) 01/2020 - 01/2016
3	Disease Progression 01/2018 - 07/2015
3	Hepatic Encephalopathy 10/2014 - 07/2013
2	Insulin Resistance 11/2021 - 01/2019
2	Kidney Diseases (Kidney Disease) 01/2021 - 12/2014
2	Atrophy 04/2020 - 01/2020
2	Pleural Effusion (Pleural Effusions) 03/2020 - 08/2014
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 10/2019 - 01/2016
2	Hyperglycemia 10/2019 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2018 - 08/2014
2	Chronic Hepatitis B 01/2017 - 08/2015
2	Arteriosclerosis 01/2016 - 06/2012
2	Pathologic Constriction (Stenosis) 01/2016 - 01/2012
2	Fatigue 04/2015 - 01/2013
2	Acute Necrotizing Pancreatitis 05/2013 - 02/2008
2	Portal Hypertension 01/2012 - 04/2010
1	Wounds and Injuries (Trauma) 05/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Body Weight (Weight, Body) 01/2022
1	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 12/2021 - 05/2011
12	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2014
11	Biomarkers (Surrogate Marker)IBA 11/2021 - 10/2012
6	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2012
6	lipoxin A4IBA 01/2019 - 02/2011
6	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 01/2014
5	CreatinineIBA 01/2022 - 06/2014
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
5	CytokinesIBA 01/2016 - 12/2013
4	AntioxidantsIBA 05/2024 - 03/2020
4	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018 - 01/2015
3	Sildenafil Citrate (Viagra)FDA Link 01/2023 - 07/2014
3	aristolochic acid I (aristolochic acid)IBA 01/2021 - 06/2014
3	Taurocholic Acid (Sodium Taurocholate)IBA 03/2020 - 02/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2020 - 01/2019
3	Insulin (Novolin)FDA Link 10/2019 - 01/2016
3	LuteolinIBA 09/2018 - 01/2015
3	ErbB Receptors (EGF Receptor)IBA 07/2018 - 08/2014
3	trichostatin A (A 300)IBA 04/2018 - 11/2014
3	Long Noncoding RNAIBA 11/2017 - 01/2017
3	Cadherins (E-Cadherin)IBA 01/2017 - 01/2015
3	CateninsIBA 01/2017 - 01/2016
3	VimentinIBA 01/2017 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 01/2014
3	Dopamine (Intropin)FDA LinkGeneric 10/2014 - 07/2013
2	Therapeutic UsesIBA 01/2023 - 01/2014
2	ResveratrolIBA 04/2022 - 12/2014
2	NitrogenIBA 01/2022 - 04/2020
2	periplocinIBA 01/2022 - 01/2021
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 04/2020
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2021 - 05/2018
2	Caspase 3 (Caspase-3)IBA 08/2020 - 01/2015
2	Sirolimus (Rapamycin)FDA Link 04/2020 - 05/2011
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2020 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 08/2015
2	InterferonsIBA 10/2019 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2015
2	LipoxinsIBA 11/2018 - 02/2011
2	cobaltous chloride (cobalt(II)chloride)IBA 09/2018 - 01/2016
2	Gefitinib (Iressa)FDA Link 07/2018 - 08/2017
2	Gemcitabine FDA Link 05/2018 - 01/2018
2	theasinensin AIBA 04/2018 - 01/2015
2	Histone Deacetylase InhibitorsIBA 04/2018 - 01/2015
2	brusatolIBA 01/2018 - 10/2017
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2017 - 01/2015
2	p38 Mitogen-Activated Protein KinasesIBA 10/2017 - 12/2013
2	CollagenIBA 07/2017 - 01/2016
2	Amylases FDA Link 01/2017 - 01/2016
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 05/2016 - 01/2014
2	SolanineIBA 01/2016 - 01/2014
2	salvianolic acid BIBA 01/2016 - 11/2015
1	HydrogelsIBA 05/2024
1	acadesineIBA 10/2022
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 07/2022
1	agrimoniinIBA 02/2022
1	AlbuminsIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 11/2021
1	Thrombopoietin (c-mpl Ligand)IBA 01/2021

Therapy/Procedure

12	Therapeutics 01/2022 - 06/2012
9	Islets of Langerhans Transplantation 01/2023 - 01/2016
6	Drug Therapy (Chemotherapy) 02/2022 - 08/2014
5	Transplantation 01/2022 - 01/2015
2	Intra-Arterial Infusions 01/2014 - 05/2013
1	Radiotherapy 02/2022